Columnist Jasmine Ramos has found dating with a disability to be frustrating and emotionally exhausting, but she holds on to ...

This article was provided by our partner, the Muscular Dystrophy Association. It has been reviewed by Bionews for accuracy ...

Extracellular vesicles (EVs) are potential biomarkers for SMA progression and Spinraza treatment response. Untreated SMA patients show elevated EV levels, which decrease with Spinraza therapy.

Researchers used long-read sequencing to find two previously unknown SMN1 deletions in two women with mild adult-onset SMA.

Pushing through her tears and fears, columnist Connie Chandler realizes that vulnerability is not the opposite of strength.

Using disease-modifying therapies may help children with SMA types 1 and 2 maintain better nutrition and prevent stunted ...

Pain medication was supposed to improve columnist Sherry Toh's functionality, but even after a year, the side effects can ...

A real-world study in Spain found adults and children with SMA show high long-term adherence to daily treatment with oral ...

Columnist Connie Chandler shares how a simple childhood craft allowed her to be genuinely seen by others and form ...

Spinraza was shown to slow lung function decline for symptomatic spinal muscular atrophy patients, but ventilation was still ...

Children with spinal muscular atrophy (SMA) given the gene therapy Zolgensma (onasemnogene abeparvovec-xioi) in infancy are maintaining motor milestones after up to a decade of follow-up, according to ...

Haloperidol, an antipsychotic, shows promise for SMA treatment. It increases SMN protein, protects motor neurons, and improves motor function in models. Further clinical evaluation is needed to ...